Our in vivo efficacy experiments show that a single local injection of 213Bi-PAI2 can completely inhibit the growth of tumour at 2 days postcell inoculation, and a single systemic (i.p.)administration at 2 days causes tumour growth inhibition in a dose-dependent manner. Here, SERPINB2 is linked to neoplasm.